BiomimX

BiomimX

BiomimX S.r.l. is a pioneer in Organ on a Chip (OoC) technology, producing the next generation of clinically relevant in-vitro models for pharmaceutical drug discovery and testing. Its proprietary platform integrates microfluidics, 3D cell culture, live human cells, and mechanical stimuli to produce "Beating Organs on a Chip" . These recapitulate, with unprecedented precision and predictability, clinically relevant models reflective of human physiology and pathophysiology. Pharma R&D is an area where animal models continue to fall short due to lack of translatability and/or lack of relevant models. Regulatory agencies in the US and Europe are now moving forward to encourage biopharma's use of more predictive non-animal models. BiomimX is poised to be a leader in this space and has gained early traction with industry. If you want to know more about our OoC models send us an e-mail at: info@biomimx.com.

Biomedical, Biotechnology, Cardiology/Cardiotoxicology, Pharmaceutical Toxicology, Regulatory Toxicology, ADME (Absorption/Distribution/Metabolism/Excretion), Cells/Tissue, In Vitro, Metabolism Studies, Microfluidics, Preclinical, Efficacy Testing, High Throughput Test Systems, Research/Testing, Safety/Risk Assessment